Here we go People....been a long wait NZT
Key points that will be covered:
• Phase 3 global clinical trial in FSGS kidney disease patients status and update
• Advanced partnering negotiations with material offers received from multiple parties for
various territories1
• Commercial opportunity and addressable market value
I must say I did feel confident that there were interested parties from attending all those conferences, expos and presentations,,
TBH I'm quite excited to see the caliber of the Multiple Parties
Ann: FSGS Study, Partnering & Commercialisation Investor Briefing, page-3
-
- There are more pages in this discussion • 109 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.5¢ |
Change
-0.010(2.20%) |
Mkt cap ! $247.9M | |||
| Open | High | Low | Value | Volume |
| 45.0¢ | 45.8¢ | 43.8¢ | $701.3K | 1.564M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 111371 | 44.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 8072 | 1 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| DXB (ASX) Chart |